Biotechnic & Histochemistry · 2020 · 19 citations · 20 references
MedicinePharmacologyPharmacotherapyChemotherapyInflammationMolecular PharmacologyCannabinoid PharmacologyInterstitial Lung DiseasePulmonary InflammationPulmonary ToxicityCannabinoid Receptor PharmacologyDrug-induced Lung InjuryFibrotic ChangeLung FibrosisLung Tissue ModelsOxidative Stress InjuryPulmonary Fibrosis ProgressionPulmonary Oxidative Stress
Bleomycin (BLM) is a chemotherapeutic agent that can cause pulmonary fibrosis. Little is known about the possible protective role of the CB2 receptor agonist, AM1241. We investigated the effects of CB2 receptor activation by AM1241 on BLM induced lung fibrosis in a rat model. BLM was administered via the trachea. Adult female Wistar rats were divided into five groups: saline (control group), BLM (BLM group), CB2 agonist (AM1241) + BLM (BLMA group), CB2 antagonist (AM630) and CB2 agonist (AM1241) + BLM (BLMA + A group), and vehicle (dimethylsulfoxide) + BLM (BLM + vehicle group). Hydroxyproline, collagen type 1, total protein, glutathione (GSH), malondialdehyde (MDA), interleukin (IL)-6 and tumor necrosis factor (TNF)-α levels were measured in lung fibrosis and control tissue using standard methods. We investigated the histopathology of lung tissue to determine the extent of fibrosis. We found significantly higher levels of hydroxyproline, TNF-α, IL-6 and total protein in the BLM group compared to the BLMA group. The level of GSH also was higher in the BLMA group compared to the BLM group. Inflammation and fibrotic changes were significantly reduced in the BLMA group. Our findings suggest that CB2 receptor activation provided protection against BLM induced pulmonary fibrosis by suppressing oxidative stress and increasing cytokines.
20
Patricia J. Sime, Robert A. Marr, David Gauldie et al. · American Journal Of Pathology · 1998 · 260 citations · Full text
Nasreen Khalil, Cynthia B. Whitman, Li Zuo et al. · Journal of Clinical Investigation · 1993 · 185 citations · Full text
The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis
Alfiya Akhmetshina, Clara Dees, Nicole Busch et al. · Arthritis & Rheumatism · 2009 · 126 citations
Medicine, Immunology, Pharmacology +15